Failure of Senescence in the Dysplasia-Melanoma Sequence: Demonstration Using a Tissue Microarray and a Revised Paradigm for Melanoma

Seminars in Oncology

Volumn 34, Issue 6, 2007, Pages 467-475

  Tuthill, Ralph J ^a   Reed, Richard J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EOSIN; HEMATOXYLIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P16;

ARTICLE; CANCER GROWTH; DYSPLASIA; DYSPLASTIC NEVUS; HUMAN; IMMUNOHISTOLOGY; MALIGNANT TRANSFORMATION; MELANOMA; NEVUS; PRIORITY JOURNAL; SENESCENCE; TISSUE MICROARRAY;

CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MELANOMA; MODELS, BIOLOGICAL; NEVUS; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 36848999233     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.09.014     Document Type: Article

References (29)

1. Lever W.F. Histopathology of the Skin (1949), Lippincott, Philadelphia, PA
2. Masson P. My conception of cellular nevi. Cancer 4 (1951) 9-38
3. Allen A., and Spitz S. Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 6 (1953) 1-45
4. Horstadius S. The Neural Crest. Its Properties and Derivatives in the Light of Experimental Research (1950), Oxford University Press, London, UK
5. Ewing J. The problems of melanoma. Br Med J 2 (1930) 852-856
6. Rwylin A. Malignant melanoma in light of the multistep theory of neoplasia. Am J Dermatopathol 11 (1989) 387-389
7. Reed R.J. Melanoma in situ: Images, segments, appellations, and implications. Hum Pathol 29 (1998) 1-3
8. Pollock P.M., Harper U.L., Hansen K.S., et al. High frequency of BRAF mutations in nevi. Nat Genet 33 (2003) 19-20
9. Curtin J.A., Fridlyand J., Kageshita T., et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 353 (2005) 2135-2147
10. Michaloglou C., Vredeveld L.C.W., Soengas M.S., et al. BRAFe600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
11. Weinberg R. Molecular mechanisms of invasion and metastasis. Pigment Cell Res 18 suppl 1 (2005) 3
12. Bennett D., and Medrano E.E. Molecular regulation of melanocyte senescence. Pigment Cell Res 15 (2002) 242-250
13. Bennett D. Human melanocyte senescence and melanoma susceptibility genes. Oncogene 22 (2003) 3063-3069
14. Gray-Schopfer V., Cheong S.C., Chong H., et al. Cellular senescence in naevi and immortalization in melanoma: A role for p16?. Br J Cancer 95 (2006) 496-505
15. Weinberg R. The Biology of Cancer (2007), Garland Science, Taylor & Francis Group, New York, NY
16. Reed R.J., Ichinose H., Clark Jr. W.H., et al. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol 2 (1975) 119-147
17. Reed R.J. Minimal deviation melanoma. In: Mihm Jr. M.C., Murphy G.F., and Kaufman N. (Eds). Pathobiology and Recognition of Malignant Melanoma (1988), Williams & Wilkins, Baltimore, MD 110-152
18. Clark Jr. W.H., Elder D.E., Guerry IV D., et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81 (1989) 1893-1904
19. Taran J., and Heenan P. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis. Cancer 91 (2001) 1822-1825
20. Karakousis G.C., Gimotty P.A., Botbyl J.D., et al. Predictors of regional nodal disease in patients with thin melanomas. Ann Surg Oncol 13 (2006) 533-541
21. Gupta P., Kuperwasser C., Brunet J.-P., et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37 (2005) 1047-1054
22. Ruhoy S., Prieto V.G., Eliason S.L., et al. Malignant melanoma with paradoxical maturation. Am J Surg Pathol 24 (2000) 1600-1614
23. Mooi W., and Peeper D. Oncogene-induced cell senescence-Halting on the road to cancer. N Engl J Med 355 (2006) 1037-1046
24. Lund H.Z., and Stobbe G.D. The natural history of the pigmented nevus; factors of age and anatomic location. Am J Pathol 25 (1949) 1117-1155
25. Helwig E. Malignant melanoma of the skin in man. In: Urbach F. (Ed). The First International Conference on The Biology of Cutaneous Cancer (1962), Government Printing Office, Washington, DC 287-295
26. Goovaerts G., and Buyssens N. Nevus cell maturation or atrophy?. Am J Dermatopathol 10 (1988) 20-27
27. Chin L., Garraway L.A., and Fisher D.E. Malignant melanoma: Genetics and therapeutics in the genomic era. Genes Dev 20 (2006) 2149-2182
28. Li W., Sanki A., Karim R.Z., et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology 38 (2006) 287-301
29. Plettenberg A., Ballaun C., Pammer J., et al. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 146 (1995) 651-659